[Efficacy analysis of PD-1/PD-L1 inhibitors in the treatment of advanced primary pulmonary lymphoepithelioma-like carcinoma: 6 case reports and literature review].

Zhang, L; Zheng, J; Fang, L J; Zhang, L; Zhou, J Y

Zhang, L; Zheng, J; Fang, L J; Zhang, L; Zhou, J Y.

Afiliación

Zhang L; Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310000, China Department of Oncology, The Second Hospital of Jiaxing, Jiaxing 314000, China.
Zheng J; Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310000, China.
Fang LJ; Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310000, China.
Zhang L; Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310000, China.
Zhou JY; Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310000, China.

Zhonghua Zhong Liu Za Zhi ; 46(6): 590-594, 2024 Jun 23.

Article en Zh | MEDLINE | ID: mdl-38880738

Asunto(s)

Antígeno B7-H1; Neoplasias Pulmonares; Receptor de Muerte Celular Programada 1; Humanos; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/patología; Receptor de Muerte Celular Programada 1/antagonistas & inhibidores; Antígeno B7-H1/antagonistas & inhibidores; Antígeno B7-H1/metabolismo; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Persona de Mediana Edad; Masculino; Femenino

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Neoplasias Pulmonares Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google